XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Stock Option (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Apr. 30, 2024
Apr. 30, 2023
Jul. 31, 2023
Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]          
Number of options, beginning outstanding balance   2,342,539 864,489 864,489  
Weighted average exercise price, beginning balance   $ 0.49 $ 0.14 $ 0.14  
Weighted average remaining contractual term (years), outstanding ending   8 years 2 months 23 days 8 years 11 months 23 days   9 years 10 months 2 days
Aggregate intrinsic value outstanding, beginning balance   $ 142,029 $ 479,539 $ 479,539  
Weighted average grant date fair value, outstanding beginning    
Number of options, beginning exercisable balance   2,219,368 864,489 864,489  
Weighted average exercise price, exercisable, beginning balance   $ 0.48 $ 0.14 $ 0.14  
Weighted average remaining contractual term (years), exercisable ending   8 years 2 months 23 days 8 years 11 months 23 days   9 years 10 months 2 days
Aggregate intrinsic value exercisable, beginning balance   $ 142,029 $ 479,539 $ 479,539  
Weighted average grant date fair value, exercisable beginning    
Number of options, granted 1,478,050   1,478,050  
Weighted average exercise price, granted     $ 0.14  
Aggregate intrinsic value, granted      
Weighted average grant date fair value, granted     $ 0.68  
Number of options, exercised      
Weighted average exercise price, exercised      
Aggregate intrinsic value, exercised      
Weighted average grant date fair value, exercised      
Number of options, cancelled/Forfeited      
Weighted average exercise price, cancelled/Forfeited      
Aggregate intrinsic value, cancelled/Forfeited      
Weighted average grant date fair value, cancelled/forfeited      
Number of options, ending outstanding balance   2,342,539   2,342,539 864,489
Weighted average exercise price, ending balance   $ 0.49   $ 0.49 $ 0.14
Aggregate intrinsic value outstanding, ending balance   $ 63,159   $ 142,029 $ 479,539
Weighted average grant date fair value, outstanding ending    
Number of options, ending exercisable balance   2,342,539   2,219,368 864,489
Weighted average exercise price, exercisable, ending balance   $ 0.49   $ 0.48 $ 0.14
Aggregate intrinsic value exercisable, ending balance   $ 63,159   $ 142,029 $ 479,539
Weighted average grant date fair value, exercisable ending    
Number of options, ending unvested balance        
Weighted average exercise price, unvested, ending balance        
Aggregate intrinsic value unvested, ending balance        
Weighted average grant date fair value, unvested ending